Back to mobile site

Incyte to acquire Vega Therapeutics for $1.25 billion upfront

June 8, 2026 7:00 AM EDT Send to a Friend
Incyte Corp. (NASDAQ: INCY) announced it has entered into a definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login